Caxton Associates LLP 10x Genomics, Inc. Transaction History
Caxton Associates LLP
- $2.87 Trillion
- Q1 2025
A detailed history of Caxton Associates LLP transactions in 10x Genomics, Inc. stock. As of the latest transaction made, Caxton Associates LLP holds 346,794 shares of TXG stock, worth $3.19 Million. This represents 0.11% of its overall portfolio holdings.
Number of Shares
346,794Holding current value
$3.19 Million% of portfolio
0.11%Shares
1 transactions
Others Institutions Holding TXG
# of Institutions
303Shares Held
104MCall Options Held
228KPut Options Held
157K-
Cathie Wood Ark Investment Management LLC | St. Petersburg, Fl12.8MShares$118 Million1.21% of portfolio
-
Vanguard Group Inc Valley Forge, PA11.1MShares$102 Million0.0% of portfolio
-
Black Rock Inc. New York, NY6.39MShares$58.8 Million0.0% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny5.38MShares$49.5 Million0.03% of portfolio
-
Sumitomo Mitsui Trust Holdings, Inc.5.36MShares$49.3 Million0.03% of portfolio
About 10x Genomics, Inc.
- Ticker TXG
- Exchange NASDAQ
- Sector Healthcare
- Industry Health Information Services
- Shares Outstandng 95,046,400
- Market Cap $874M
- Description
- 10x Genomics, Inc., a life science technology company, develops and sells instruments, consumables, and software for analyzing biological systems in North America, Europe, the Middle East, Africa, China, and the Asia Pacific. The company provides chromium and chromium connect instruments, microfluidic chips, slides, reagents, and other consumabl...